Emergent BioSolutions (EBS) Tops Q1 EPS by 23c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $5.93 -1.17%
EPS Growth %: -138.7%
Financial Fact:
Weighted-average number of shares - basic: 40.47M
Today's EPS Names:
SUNB, CULP, KFY, More
EPS Growth %: -138.7%
Financial Fact:
Weighted-average number of shares - basic: 40.47M
Today's EPS Names:
SUNB, CULP, KFY, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q1 EPS of $0.16, $0.23 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $111 million versus the consensus estimate of $101.83 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Texas Instruments (TXN) Reiterated at Neutral by Cantor Fitzgerald on Upside to Earnings Power
- ABM Industries (ABM) PT Raised to $51.50 at UBS, Neutral Rating Maintained
- Chewy (CHWY) Reports In-Line Q2 EPS, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
